Clinical Trials and Pulmonary Fibrosis
You may be a candidate for a clinical trial of a new pulmonary fibrosis (PF) treatment. Clinical trials are performed in order to test if experimental treatments are safe and effective for the treatment of a disease. Every drug that is approved today was once tested in a clinical trial.
Several research studies are being conducted about pulmonary fibrosis. Participating in a clinical trial may give you access to new treatment options and also help future PF patients. Some of the existing PF clinical trials are looking at drugs that can slow or block fibrosis, stem cell therapy and PF genes.
Talk to your doctor to find out if a clinical trial is right for you and visit our clinical trial section to learn more.
Reviewed and approved by the American Lung Association Scientific and Medical Editorial Review Panel. Last reviewed February 5, 2018.
Page Last Updated: March 13, 2018
Sign up for the latest lung health news delivered right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.